Pulmonary inhalation aerosols for targeted antibiotics drug delivery

Chun Woong Park, Heidi M. Mansour, Don Hayes

Research output: Contribution to specialist publicationArticle

16 Scopus citations


Targeted pulmonary drug delivery of antibiotics by inhalation aerosols can play significant roles in the treatment of cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD) and in other pulmonary diseases where chronic airway infections exist. Direct administration to the lung as targeted pulmonary inhalation aerosol delivery is uniquely able to provide for high dose levels of drugs at the target site of action without systemic side effects. This review presents an overview of pulmonary inhalation aerosols, types of inhalation aerosols, aerosol formulation additives and present current research in the targeted pulmonary drug delivery of antibiotics for the treatment of pulmonary infections. Clinical trials of antibiotic inhalation aerosols are also discussed.

Original languageEnglish (US)
Specialist publicationEuropean Pharmaceutical Review
StatePublished - 2011

ASJC Scopus subject areas

  • General Pharmacology, Toxicology and Pharmaceutics
  • Molecular Medicine
  • Biophysics
  • Biochemistry
  • Biotechnology


Dive into the research topics of 'Pulmonary inhalation aerosols for targeted antibiotics drug delivery'. Together they form a unique fingerprint.

Cite this